About us


At the Department of Biomedicine we conduct research in human biology and diseases and educate students within these fields. The department also provides formalized consultancy assignments on matters of pharmacotherapy.

The department was formed in 2011 by the merger of six biomedical departments. Our aim is to gain a better understanding of diseases at the molecular and cellular level - by bridging the gap between natural science and clinical medicine and by using the results for improved diagnostics, counselling and patient treatment.

Do you want to work with us?
We have exciting job opportunities within a broad range of academic areas on a regular basis. Read more about working with us or see the list of vacant positions at Biomedicine.

What we do and where we work

Biomedicine bridges the divide between natural science and clinical medicine, and the results are used to improve diagnosis, counselling and treatment of patients. The research is divided into four main research themes and the department heads and participates in a series of research centres.

The department holds overall responsibility for the bachelor's degree programme in medicine and contributes to several other degree programmes.

See the list of educational activities.

The Skou Building is the daily place of work for more than 300 researchers, laboratory technicians and students. New knowledge about human health and diseases is created in the new and advanced laboratories.

More about the Skou Building.

The Skou Building's 3,000 m2 laboratory animal facility has room for approx. 30,000 mice and rats which are used for research into diseases.

More about the laboratory animal facility.

Facts about the Department of Biomedicine

Academic Staff




PhD Students




Developing new drugs

From knowledge to company

When you conduct research into diseases at cellular and molecular level, you can also discover new knowledge that may suggest other types of treatment. A number of researchers have established companies which are in the process of developing new drugs on the basis of their basic scientific research for the benefit of patients.